1. Home
  2. RGTIW vs IOVA Comparison

RGTIW vs IOVA Comparison

Compare RGTIW & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTIW

Rigetti Computing Inc.

HOLD

Current Price

$5.58

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.67

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTIW
IOVA
Founded
2013
2007
Country
United States
United States
Employees
164
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
RGTIW
IOVA
Price
$5.58
$3.67
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$9.11
AVG Volume (30 Days)
88.0K
15.9M
Earning Date
03-11-2025
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$11,892,000.00
N/A
Revenue This Year
N/A
$51.55
Revenue Next Year
N/A
$37.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$1.64
52 Week High
$46.78
$5.63

Technical Indicators

Market Signals
Indicator
RGTIW
IOVA
Relative Strength Index (RSI) 35.27 48.08
Support Level $5.07 $2.02
Resistance Level $6.63 $4.34
Average True Range (ATR) 0.69 0.32
MACD -0.09 -0.12
Stochastic Oscillator 6.11 12.50

Price Performance

Historical Comparison
RGTIW
IOVA

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: